Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122161 · ClinicalTrials.gov registry record · Phase 3
Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 190
- Enrollment target
NCT00122161: Completed Phase 3 study, sponsored by US Department of Veterans Affairs.
NCT00122161 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 190 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00122161, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 190 participants
- Enrollment target
Study Summary
Clinical trial of implementation of clinical practice guidelines for managing hypertension in primary care clinics.
Interventions
- BEHAVIORAL ATHENA Decision Support System, An Automated Clinical Decision Support System for Health Care Providers
- BEHAVIORAL Profiling performance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Est. Completion | 2005-09 |
| Phase | Phase 3 |
What the finished NCT00122161 record still lists
NCT00122161 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which ATHENA Decision Support System, An Automated Clinical Decision Support System for Health Care Providers is the first listed.
NCT00122161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00122161 about?
NCT00122161 is a clinical study titled "Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation". Clinical trial of implementation of clinical practice guidelines for managing hypertension in primary care clinics.
What is the current status of trial NCT00122161?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 190 participants. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00122161?
The interventions under investigation include: ATHENA Decision Support System, An Automated Clinical Decision Support System for Health Care Providers (BEHAVIORAL), Profiling performance (BEHAVIORAL).
Who is sponsoring clinical trial NCT00122161?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00122161's enrollment target sits among peer trials
190 1402nd of 2000 higher than 593 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults